ReviewFrontiers in pharmacology2023

Comparative safety of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis.

Kinga Krawczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.